Search Results - "Duarte, Gislaine"

Head-to-head comparison of [68Ga]Ga-PSMA-11 and [18F]FDG PET/CT in multiple myeloma by Souza, Stephan P. M., Frasson, Fernanda C., Takahashi, Maria Emilia S., Duarte, Gislaine B. O., Castro, Vania P., Pericole, Fernando V., Velloso, Licio A., De Souza, Carmino A., Lorand-Metze, Irene, Santos, Allan O., Ramos, Celso D.

“…Purpose The aim of this study was to compare [ 18 F]FDG and [ 68 Ga]Ga-PSMA-11 PET/CT image findings in patients with multiple myeloma (MM). Methods Twenty…”
Get full text

Intensity of bone involvement: a quantitative 18F-FDG PET/CT evaluation for monitoring outcome of multiple myeloma by Takahashi, Maria Emilia Seren, Mosci, Camila, Duarte, Gislaine O., Pericole, Fernando V., Metze, Konradin, Lorand-Metze, Irene G.H., Ramos, Celso D.

“…The parameter intensity of bone involvement (IBI) was recently proposed to quantitatively assess patients with multiple myeloma using…”
Get full text

Kinetics of BCR::ABL1 transcript levels and molecular relapse after tyrosine kinase inhibitors discontinuation in chronic myeloid leukemia patients: preliminary results from the DES-CML study by Murbach, Bruna, Duarte, Gislaine, Palma, Leonardo Carvalho, Miranda, Eliana, Duffles, Guilherme, Furlin, Graziele Pavan, Toni, Isabella, De Souza, Carmino, Binelli, Larissa, Bassan, Vitor Leonardo, de Castro, Fabiola Attie, de Figueiredo-Pontes, Lorena Lobo, Pagnano, Katia Borgia Barbosa

“…Tyrosine kinase inhibitors (TKI) have revolutionized the treatment of patients with chronic myeloid leukemia. Patients who achieve sustained deep molecular…”
Get full text

Modeling of soybean yield using symmetric, asymmetric and bimodal distributions: implications for crop insurance by Duarte, Gislaine V., Braga, Altemir, Miquelluti, Daniel L., Ozaki, Vitor A.

“…Over the years, many papers used parametric distributions to model crop yields, such as: normal (N), Beta, Log-normal and the Skew-normal (SN). These models…”
Get full text

Imbalance between proliferation and in vitro apoptosis rates predicts progression in chronic lymphocytic leukemia by Lorand-Metze, Irene, Oliveira-Duarte, Gislaine B., Metze, Konradin

Get full text

Efficacy and safety of pioglitazone in a phase 1/2 imatinib discontinuation trial (EDI‐PIO) in chronic myeloid leukemia with deep molecular response by Pagnano, Katia B.B., Lopes, Ana Beatriz P., Miranda, Eliana C., Delamain, Márcia T., Duarte, Gislaine O., Rodrigues, Bruna R.V., Povoa, Valquiria M.O., Furlin, Graziele C.P., Vianna, Jessica C., Silva, Matheus A.S., De Souza, Carmino A, De Paula, Erich V

Get full text

Using Antigen Expression of Leukemic Cells for a Fast Screening of Acute Promyelocytic Leukemia by Flow Cytometry by Ceni-Silva, Vitória, Pagnano, Kátia, Duarte, Gislaine, Pellegrini, Marina, Duarte, Bruno, Metze, Konradin, Lorand-Metze, Irene

“…(1) Background: Acute promyelocytic leukemia is curable, but bleeding complications still provoke a high early mortality. Therefore, a fast diagnosis is needed…”
Get full text

PB1977: EVALUATION OF ANTIBODY RESPONSES AMONG FIVE DIFFERENT SARS-COV-2 VACCINES IN CHRONIC MYELOID LEUKEMIA PATIENTS – A REAL-WORLD STUDY by Toreli, Ana Carolina, Galvis, Marisol Miranda, Carvalho, Marcelo Addas, Miranda, Eliana, Fechio, Leonardo, Duarte, Adriana Da Silva Santos, Zangirolami, Audrey Basso, Duarte, Gislaine, Medina, Samuel Souza, Pericole, Fernando, Benites, Bruno, Ravindra, Kolhe, Jones, Kimya, Singh, Harmanpreet, Saad, Sara Olalla, de Souza, Carmino Antonio, Cortes, Jorge, Pagnano, Katia

Get full text

Thalidomide plus dexamethasone as a maintenance therapy after autologous hematopoietic stem cell transplantation improves progression-free survival in multiple myeloma by Maiolino, Angelo, Hungria, Vania T.M., Garnica, Marcia, Oliveira-Duarte, Gislaine, Oliveira, Luciana C.O., Mercante, Daniel R., Miranda, Eliana C., Quero, Adriana A., Peres, Ana L.M., Barros, José C., Tanaka, Paola, Magalhães, Roberto P., Rego, Eduardo M., Lorand-Metze, Irene, Lima, Carmen S.P., Renault, Ilana Z., Braggio, Esteban, Chiattone, Carlos, Nucci, Marcio, de Souza, Carmino A.

“…Despite the good response of stem cell transplant (SCT) in the treatment of multiple myeloma (MM), most patients relapse or do not achieve complete remission,…”
Get full text

Peripheral lymphocyte subsets as predicting factors for molecular recurrence after imatinib discontinuation in a phase 2 imatinib discontinuation trial in patients with chronic myeloid leukemia by Braga, Arthur Gomes Oliveira, Barbosa Pagnano, Katia Borgia, Campioni, Marina Dal'Bó Pelegrini, Lopes, Ana Beatriz Pascoal, Duarte, Gislaine Oliveira, Metze, Konradin, Lorand-Metze, Irene

“…Treatment-free remission (TFR) is successful in half of the patients with chronic myeloid leukemia who discontinue Imatinib (IM) after sustained molecular…”
Get full text

Survival differences in multiple myeloma in Latin America and Asia: a comparison involving 3664 patients from regional registries by Hungria, Vania T. M., Lee, Jae Hoon, Maiolino, Angelo, de Queiroz Crusoe, Edvan, Martinez, Gracia, Bittencourt, Rosane, Duarte, Gislaine Oliveira, Fantl, Dorotea Beatriz, Navarro, Juan Ramon, Conte, Guillermo, Gomez-Almaguer, David, Ruiz-Argüelles, Guillermo J., Kim, Kihyun, Shimizu, Kazuyuki, Chen, Wenming, Huang, Shang-YI, Chng, Wee-Joo, Chim, Chor Sang, Nawarawong, Weerasak, Durie, Brian

“…In previous observational studies, we have separately characterized patients with multiple myeloma (MM) both from Latin America (LA) and from Asia. Here, we…”
Get full text

Evaluation of anemia after long-term treatment with imatinib in chronic myeloid leukemia patients in chronic phase by Moura, Muriel Silva, Benevides, Thais Celi Lopes, Delamain, Marcia Torresan, Duarte, Gislaine Oliveira, Percout, Priscila Oliveira, Dias, Maria Almeida, Zulli, Roberto, Souza, Carmino Antonio de, Lorand-Metze, Irene, Pagnano, Katia Borgia Barbosa

“…The incidence of grade 3-4 anemia was reported to be 3% with imatinib therapy for newly diagnosed chronic myeloid leukemia (CML) in the chronic phase (CP)…”
Get full text

Treatment with dasatinib or nilotinib in chronic myeloid leukemia patients who failed to respond to two previously administered tyrosine kinase inhibitors – a single center experience by Ribeiro, Beatriz Felicio, Miranda, Eliana C M, de Albuquerque, Dulcinéia Martins, Delamain, Márcia T, Oliveira-Duarte, Gislaine, Almeida, Maria Helena, Vergílio, Bruna, da Silveira, Rosana Antunes, Oliveira-Duarte, Vagner, Lorand-Metze, Irene, De Souza, Carmino A, Pagnano, Katia B B

“…To evaluate hematological, cytogenetic and molecular responses as well as the overall, progression-free and event-free survivals of chronic myeloid leukemia…”
Get full text

Management of chronic myeloid leukemia during pregnancy: a retrospective analysis at a single center by Moura, Ariella Cássia de, Delamain, Márcia Torresan, Duarte, Gislaine Borba Oliveira, Lorand-Metze, Irene, Souza, Cármino Antônio de, Barbosa Pagnano, Kátia Borgia

“…We analyzed the management and outcomes of pregnancies of patients with chronic myeloid leukemia at a single center over fifteen years. Among the 203 CML…”
Get full text

The Importance of Bone Marrow Lymphocyte Subtypes As Predicting Factors for Molecular Recurrence in Patients with Chronic Myeloid Leukemia after Discontinuation of Imatinib by Braga, Arthur Gomes Oliveira, Pagnano, Katia B, Campioni, Marina Dal'Bó Pelegrini, Lopez, Ana Beatriz P, Metze, Konradin, Duarte, Gislaine B O, Lorand-Metze, Irene

“…Introduction: in recent years the feasibility of the discontinuation of tyrosine kinase treatment in chronic myeloid leukemia (CML) has been proven, and…”
Get full text

Meningeal Myelomatosis Illustrated on FLAIR Post-Contrasted Images by Silva, Natalia, Delamain, Marcia, Duarte, Gislaine, Reis, Fabiano

Get more information

Serological Response after Two Doses of Sars-Cov-2 Vaccines in CML Patients - a Prospective Study of a Brazilian Center by Mourão Toreli, Ana Carolina, Fechio, Leonardo, Duarte, Adriana Silva Santos, Basso, Audrey, Duarte, Gislaine B O, Medina, Samuel de Souza, Amarante, Guilherme Brasil Duffles, Pericole, Fernando Vieira, Benites, Bruno Deltreggia, Zulli, Roberto, Souza, Carmino Antonio, Addas Carvalho, Marcelo, Pagnano, Katia B

Get full text

Developing a Simple Algorithm Based on Multiparameter Flow Cytometry for Fast Screening of Acute Promyelocytic Leukemia by Ceni, Vitória Ceni, Pagnano, Katia B, Duarte, Gislaine B O, Pellegrini, Marina DB, Duarte, Bruno Kosa, Metze, Konradin, Lorand-Metze, Irene

“…Introduction: Acute promyelocytic leukemia (APL) is a genetically and molecularly well-defined type of acute leukemia that is curable but has a frequent early…”
Get full text

A Survey Conducted during COVID-19 Pandemic Among Brazilian Chronic Myeloid Leukemia and Philadelphia-Negative Myeloproliferative Neoplasms Patients by Fechio, Leonardo, Mota, Ana Vitória Ferreira, Bortolini, Jaisson, Duarte, Gislaine B O, Delamain, Marcia, Medina, Samuel S, Amarante, Guilherme Brasil Duffles, Pericole, Fernando Vieira, Machado, Hanalydia, Addas Carvalho, Marcelo, Pagnano, Katia B

“…Introduction: COVID-19 has severely affected the Brazilian population. By July 2021, the incidence was 19,9 million cases and 556.000 deaths. Recent studies…”
Get full text

The Prognostic Impact of HMGCLL1 Gene Variant on Treatment Outcomes in Chronic Myeloid Leukemia (CML) Patients: Adverse Impact on the Response, Failure, and Progression with Imatinib Which Can be Abrogated By the Use of 2nd Generation Tyrosine Kinase Inhibitor (TKI) Upfront Therapy by Perusini, Maria Agustina, Kim, Taehyung Simon, Žácková, Daniela, Pagnano, Katia B, Mayer, Jiří, Pavlovsky, Carolina, Ježíšková, Ivana, Kvetková, Anežka, Jurček, Tomáš, Moiraghi, Beatriz, Varela, Ana Ines, Bianchini, Michele, Lopes, Ana Beatriz Pascoal, Duarte, Gislaine B O, Yoo, Young Seok, Souza, Carmino Antonio, Medeiros, Jessie, Lee, Hye Won, Kim, Kyoung Ha, Yi, Seong Yoon, Chang, Myung Hee, Abelson, Sagi, Kim, Dennis Dong Hwan

Get full text